We provide molecular rapid tests for the on-site detection of Mycoplasma contamination. Other current procedures pose many challenges for the biotechnology industry as well as R&D laboratories, as they are time-consuming, laborious, costly but mostly unreliable. Due to our extensive work experience in microbiology diagnostic laboratories, we have developed test kits which set new standards in terms of reliability, rapidity and
performance simplicity.
certus molecular diagnostics ag was founded in March 2017 by the two former co-workers Samuel Zürcher (physician) and Alexander Lüthi (PhD in Biology). Not only has the young company won several entrepreneurial awards and competitions, but so far it has also launched multiples products internationally.